Skip to content

Assessment Study of Faciocraniosynostosis by Craniofacial Osteodistraction

Respiratory Improvement of Faciocraniosynostosis by Craniofacial Osteodistraction

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01022008
Acronym
CRANIORESP
Enrollment
14
Registered
2009-12-01
Start date
2009-09-01
Completion date
2014-09-01
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faciocraniosynostoses

Keywords

Exorbitism, Upper respiratory airways, Osteodistraction, Polysomnography

Brief summary

Context. Faciocraniosynostoses present with an insufficient growth of the craniofacial skeleton due to premature fusion of skull and facial sutures. There are prenatal conditions with functional (risk of raised intracranial pressure) and morphological consequences (exorbitism, and impairment of upper respiratory airways), the severity of which justifies an early surgical treatment based on craniofacial osteotomies and osteodistraction techniques. Distraction techniques were started in our unit eleven years ago, and never ceased to be modified: Recent improvements allowed better correction of exorbitism and therefore reduction of visual risks. But the improvements of the respiratory function remain insufficient. The initial evaluations of the respiratory functions were based on blood oxygenation monitoring, and showed real improvement. But we have routinely screened our patients with complete polysomnography examinations for the past year, and this has always revealed the existence of severe sleep apnea syndromes that we fail to correct completely, although there were slightly improved. The aim of this PHRC protocol is : * the qualitative and quantitative improvement of the respiratory status with a reinforced task force group including the specialists in genuine multidisciplinary approach. * A modification of the surgical technique including modifications of the existing distraction devices, an increased number of implanted devices, and maybe a change in the surgical strategy.

Detailed description

Study design. This is a monocentric study, the patient being its own control. Due to the extremely low incidence of these conditions, it is foreseen to include twelve patients per year, during two years, which represent 24 patients in total with a minimum follow-up of one year. Evaluation criteria. The main evaluation criteria are the polysomnography variables (sleep apnea index, characterization of obstructive versus central respiratory events, the oxygenation pattern through the night), which will be performed before and after surgery (6 and 12 months post-op). The secondary criteria are the exorbitism correction analysed with the globe protrusion index and the rate of infections. A multidisciplinary task force group has already been structured in Necker Hospital. Expected results. We expect to analyze and correct all the sleep apnea syndromes. Many modifications could be made on the distractors, including removal of the activation rods, bioresorbable parts, as well as the modification of the surgical techniques.

Interventions

DEVICEOsteodistraction techniques

Treatment based on craniofacial osteotomies and osteodistraction techniques.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* age under 18 years * faciocraniosynostosis * surgery indication to craniofacial osteotomies * informed consent * social security

Exclusion criteria

* no possibilities of follow-up during one year post-surgery * history of radiotherapy * acquired or hereditary immunodeficiency syndromes * mental retardation * bone conditions could not support distractors

Design outcomes

Primary

MeasureTime frame
Improvement of respiratory function6 months and 1 year

Secondary

MeasureTime frame
Otorhinolaryngology events6 months and one year
Post-surgery infectionspost surgery

Countries

France

Contacts

PRINCIPAL_INVESTIGATOREric Arnaud, MD, PhD

Assistance Publique Hopitaux de Paris

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026